These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9537976)

  • 1. Endometrial cancer: current concepts and management.
    Ball HG; Elkadry EA
    Surg Oncol Clin N Am; 1998 Apr; 7(2):271-84. PubMed ID: 9537976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K
    Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial cancer. Prevention, detection, management, and follow up.
    Elit L
    Can Fam Physician; 2000 Apr; 46():887-92. PubMed ID: 10790821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.
    Saadat M; Truong PT; Kader HA; Speers CH; Berthelet E; McMurtrie E; Olivotto IA
    Cancer; 2007 Jul; 110(1):31-7. PubMed ID: 17510927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
    Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
    Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of women with surgical stage II endometrial cancer.
    Eltabbakh GH; Moore AD
    Gynecol Oncol; 1999 Jul; 74(1):80-5. PubMed ID: 10385555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial cancer, types, prognosis, female hormones and antihormones.
    Ulrich LS
    Climacteric; 2011 Aug; 14(4):418-25. PubMed ID: 21426234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
    Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
    Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endometrial carcinoma: which radiotherapy for which patient?].
    Barillot I; Maingon P
    Cancer Radiother; 2003 Nov; 7 Suppl 1():1s-7s. PubMed ID: 15124538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches.
    Barakat RR; Lev G; Hummer AJ; Sonoda Y; Chi DS; Alektiar KM; Abu-Rustum NR
    Gynecol Oncol; 2007 Apr; 105(1):150-6. PubMed ID: 17197012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.
    Mariani A; Dowdy SC; Keeney GL; Long HJ; Lesnick TG; Podratz KC
    Gynecol Oncol; 2004 Oct; 95(1):120-6. PubMed ID: 15385120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer.
    Goudge C; Bernhard S; Cloven NG; Morris P
    Gynecol Oncol; 2004 May; 93(2):536-9. PubMed ID: 15099975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
    Ma SK; Zhang HT; Wu LY; Liu LY; Li B
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México].
    Ruvalcaba-Limón E; Cantú-de-León D; León-Rodríguez E; Cortés-Esteban P; Serrano-Olvera A; Morales-Vásquez F; Sosa-Sánchez R; Poveda-Velasco A; Crismatt-Zapata A; Santillán-Gómez A; Aguilar-Jiménez C; Alanís-López P; Alfaro-Ramírez P; Alvarez-Avitia MA; Aranda-Flores CE; Arias-Ceballos JH; Arrieta-Rodríguez O; Barragán-Curiel E; Botello-Hernández D; Brom-Valladares R; Cabrera-Galeana PA; Cantón-Romero JC; Capdeville-García D; Cárdenas-Sánchez J; Castorena-Roji G; Cepeda-López FR; Cervantes-Sánchez G; Cetina-Pérez Lde C; Coronel-Martínez JA; Cortés-Cárdenas SA; Cruz-López JC; de la Garza-Salazar JG; Díaz-Romero C; Dueñas-González A; Valle-Solís AE; Escudero-de los Ríos P; Flores-Alvarez E; García-Matus R; Gerson-Cwilich R; González-Enciso A; González-de-León C; Guevara-Torres AG; Herbert-Núñez GS; Hernández-Hernández C; Hernández-Hernández DM; Isla-Ortiz D; Jesús-Sandoval R; Jiménez-Cervantes C; Kuri-Exsome R; López-Obispo JL; Maffuz-Aziz A; Martínez-Barrera LM; Medina-Castro JM; Montalvo-Esquivel G; Mora-Aguilar VH; Morales-Palomares MA; Morán-Mendoza A; Morgan-Villela G; Mota-García A; Muñoz-González DE; Murillo-Cruz DA; Novoa-Vargas A; Ochoa-Carrillo FJ; Oñate-Ocaña LF; Ortega-Rojo A; Palacios-Martínez AG; Palomeque-López A; Pérez-Montiel MD; Quijano-Castro F; Rivera-Rivera S; Rivera-Rubí LM; Robles-Flores JU; Rodríguez-Trejo A; Salas-Gonzáles E; Silva JA; Solorza-Luna G; Souto-del-Bosque R; Tirado-Gómez LL; Torrescano-González S; Torres-Lobatón A; Trejo-Durán E; Villavicencio-Valencia V; Gallardo-Rincón D;
    Rev Invest Clin; 2010; 62(6):583, 585-605. PubMed ID: 21416918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.
    Schlesinger C; Kamoi S; Ascher SM; Kendell M; Lage JM; Silverberg SG
    Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.